These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 1952268

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. A new study demonstrates the efficacy of naftidrofuryl in the treatment of intermittent claudication. Findings of the Naftidrofuryl Clinical Ischemia Study (NCIS).
    Kieffer E, Bahnini A, Mouren X, Gamand S.
    Int Angiol; 2001 Mar; 20(1):58-65. PubMed ID: 11342997
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Increase of walking capacity after acute aminophylline administration in intermittent claudication.
    Picano E, Testa R, Pogliani M, Lattanzi F, Gaudio V, L'Abbate A.
    Angiology; 1989 Dec; 40(12):1035-9. PubMed ID: 2596736
    [Abstract] [Full Text] [Related]

  • 27. [Intermittent venous claudication: a rarely diagnosed walking disability].
    Brülisauer M, Jäger K, Bollinger A.
    Schweiz Med Wochenschr; 1987 Jan 24; 117(4):123-6. PubMed ID: 3823823
    [Abstract] [Full Text] [Related]

  • 28. Naftidrofuryl can enhance the quality of life in patients with intermittent claudication.
    Spengel F, Brown TM, Poth J, Lehert P.
    Vasa; 1999 Aug 24; 28(3):207-12. PubMed ID: 10483329
    [Abstract] [Full Text] [Related]

  • 29. Comparison of safety and efficacy of buflomedil and naftidrofuryl in the treatment of intermittent claudication.
    Rosas G, Cerdeyra C, Lucas MA, Parano JR, Villa JJ.
    Angiology; 1981 May 24; 32(5):291-7. PubMed ID: 7235299
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Plethysmographic measurements of calf blood flow, and Xe-133 clearance from the calf muscle in patients with intermittent claudication.
    Hlavová A, Linhart J, Prerovský I, Oppelt A, Vavrejn B.
    Cor Vasa; 1968 May 24; 10(2):99-109. PubMed ID: 5706099
    [No Abstract] [Full Text] [Related]

  • 33. Measurement of peripheral blood flow in patients with peripheral artery disease: Methods and considerations.
    Salisbury DL, Brown RJ, Bronas UG, Kirk LN, Treat-Jacobson D.
    Vasc Med; 2018 Apr 24; 23(2):163-171. PubMed ID: 29458301
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Long-term effects of ticlopidine on lower limb blood flow, ankle/brachial index and symptoms in peripheral arteriosclerosis. A double-blind study. The STIMS Group in Lund. Swedish Ticlopidine Multicenter Study.
    Fagher B.
    Angiology; 1994 Sep 24; 45(9):777-88. PubMed ID: 8092543
    [Abstract] [Full Text] [Related]

  • 36. Study of the antiischemic action of EGb 761 in the treatment of peripheral arterial occlusive disease by TcPo2 determination.
    Mouren X, Caillard P, Schwartz F.
    Angiology; 1994 Jun 24; 45(6):413-7. PubMed ID: 8203766
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Intra-arterial infusion treatment with prostaglandin E1 in patients with intermittent claudication].
    Rudofsky G.
    Wien Klin Wochenschr; 1988 Jul 15; 100(14):484-8. PubMed ID: 3062906
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Accuracy of a method using short inhalation of (15)O-O(2) for measuring cerebral oxygen extraction fraction with PET in healthy humans.
    Hattori N, Bergsneider M, Wu HM, Glenn TC, Vespa PM, Hovda DA, Phelps ME, Huang SC.
    J Nucl Med; 2004 May 15; 45(5):765-70. PubMed ID: 15136624
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.